Factor V Leiden and prothrombin gene mutation: Risk factors for osteonecrosis of the femoral head in adults

Clinical Orthopaedics and Related Research

Volumn 425, Issue , 2004, Pages 168-172

  Björkman, Anders ^a   Svensson, Peter J ^a   Hillarp, Andreas ^a   Burtscher, Isabella M ^a   Rünow, Anders ^a   Benoni, Göran ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; CORTICOSTEROID; PROTHROMBIN;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BONE NECROSIS; FEMALE; FEMUR HEAD; GENE FREQUENCY; GENE MUTATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PERTHES DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

EID: 4043052344     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arruda VR, Belangero WD, Ozelo MC, et al: Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease. J Pediatr Orthop 19:84-87, 1999.
2. Bertina RM, Koeleman BPC, Koster T, et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67, 1994.
3. Castro Jr FP, Harris MB: Differences in age, laterality, and Steinberg stage at initial presentation in patients with steroid-induced, alcohol-induced, and idiopathic femoral head osteonecrosis. J Arthroplasty 14:672-676, 1999.
4. Coleman SS, Compere CL: Femoral neck fractures: Pathogenesis of avascular necrosis, nonunion and late degenerative changes. Clin Orthop 20:247-265, 1961.
5. Coventry MB, Beckenbaugh RD, Nolan DR, Ilstrup DM: 2012 total hip arthroplasties: A study of postoperative course and early complications. J Bone Joint Surg 56A:273-284, 1974.
6. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008, 1993.
7. Emmerich J, Rosendaal FR, Cattaneo M, et al: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism: Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Thromb Haemost 86:809-816, 2001.
8. Glueck CJ, Brandt G, Gruppo R, et al: Resistance to activated protein C and Legg-Perthes disease. Clin Orthop 338:139-152, 1997.
9. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P: Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 386:19-33, 2001.
10. Glueck CJ, Freiberg R, Gruppo R, et al: Thrombophilia and Hypofibrinolysis: Reversible Pathogenetic Etiologies of Osteonecrosis. In Urbaniak JR, Jones Jr JP (eds). Osteonecrosis: Etiology Diagnosis and Treatment. Rosemont, IL, American Academy of Orthopaedic Surgeons 105-110, 1997.
11. Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P: Thrombophilia and hypofibrinolysis: Pathophysiologies of osteonecrosis. Clin Orthop 334:43-56, 1997.
12. Gruppo R, Glueck CJ, Wall E, Roy D, Wang P: Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation. J Pediatr 132:885-888, 1998.
13. Hansson PO, Welin L, Tibblin G, Eriksson H: Deep vein thrombosis and pulmonary embolism in the general population: 'The study of men born in 1913'. Arch Intern Med 157:1665-1670, 1997.
14. Hayek S, Kenet G, Lubetsky A, et al: Does thrombophilia play an aetiological role in Legg-Calve-Perthes disease? J Bone Joint Surg 818:686-690, 1999.
15. Hillarp A, Zöller B, Svensson PJ, Dahlbäck B: The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 78:990-992, 1997.
16. Hirota Y, Hotokebuchi T, Sugioka Y: Idiopathic Osteonecrosis of the Femoral Head: Nationwide Epidemiologic Studies in Japan. In Urbaniak JR, Jones Jr JP (eds). Osteonecrosis: Etiology Diagnosis and Treatment. Rosemont, IL, American Academy of Orthopaedic Surgeons 51-58, 1997.
17. Hresko MT, McDougall PA, Gorlin JB, et al: Prospective reevaluation of the association between thrombotic diathesis and Legg-Perthes disease. J Bone Joint Surg 84A:1613-1618, 2002.
18. Jacobs B: Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop 130:51-67, 1978.
19. Jones Jr JP: Intravascular coagulation and osteonecrosis. Clin Orthop 277:41-53, 1992.
20. Kealey WDC, Mayne EE, McDonald W, et al: The role of coagulation abnormalities in the development of Pertheś disease. J Bone Joint Surg 82B:744-746, 2000.
21. Kirkwood BR: Cohort and Case-Control Studies. In Kirkwood BR (ed). Essentials of Medical Statistics. Oxford, Blackwell Scientific Publications 177-183, 1988.
22. Koster T, Rosendaal FR, de Ronde H, et al: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503-1506, 1993.
23. Mankin HJ: Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326:1473-1479, 1992.
24. Plakseychuk AY, Shah M, Varitimidis SE, Rubash HE, Sotereanos D: Classification of osteonecrosis of the femoral head: Reliability, reproducibility, and prognostic value. Clin Orthop 386:34-41, 2001.
25. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.
26. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 346:1133-1134, 1995.
27. Rosendaal FR: Risk factors for venous thrombosis: Prevalence, risk, and interaction. Semin Hematol 34:171-187, 1997.
28. Sevitt S: Avascular necrosis and revascularisation of the femoral head after intracapsular fractures: A combined arteriographic and histological necropsy study. J Bone Joint Surg 468:270-296, 1964.
29. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522, 1994.
30. Svensson PJ, Zöller B, Mattiasson I, Dahlbäck B: The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis. J Intern Med 241:379-385, 1997.
31. Zöller B, Svensson PJ, He X, Dahlbäck B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 94:2521-2524, 1994.